WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.76%)Nav, as on 08-08-2025

  • Previous Nav

  • Net Change on 08-08-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 1.24 21.62 18.52 1.80 8,736.57
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 7.36 26.32 21.08 1.89 6,103.96
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 9.20 25.55 20.15 1.93 4,026.55
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 2.54 20.10 18.29 1.93 2,908.21
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 1.47 21.94 18.62 2.11 1,339

Fund Holdings as on 31-July-2025

  • Max Healthcare Institute Limited

  • Sun Pharmaceutical Industries Limited

  • Fortis Healthcare Limited

  • Cipla Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Laurus Labs Limited

  • Divi's Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • Anthem Biosciences Limited

  • Net Receivables / (Payables)

  • Apollo Hospitals Enterprise Limited

  • Abbott India Limited

  • Glenmark Pharmaceuticals Limited

  • Thyrocare Technologies Limited

  • Torrent Pharmaceuticals Limited

  • Gland Pharma Limited

  • Vijaya Diagnostic Centre Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Clearing Corporation of India Ltd

  • Kovai Medical Center and Hospital Limited

  • Emcure Pharmaceuticals Limited

  • Sai Life Sciences Limited

  • Eris Lifesciences Limited

  • Ajanta Pharma Limited

  • Neuland Laboratories Limited

  • Jupiter Life Line Hospitals Limited

  • Pfizer Limited

  • AstraZeneca Pharma India Limited

  • 91 Days Tbill (MD 02/10/2025)

  • Lupin Limited

  • Alembic Pharmaceuticals Limited

  • Navin Fluorine International Limited

  • Acutaas Chemicals Limited

  • Piramal Pharma Limited

  • FDC Limited

  • Shilpa Medicare Limited

  • Rainbow Childrens Medicare Limited

  • 91 Days Tbill (MD 01/08/2025)

  • Strides Pharma Science Limited

  • Supriya Lifescience Limited

  • Shaily Engineering Plastics Limited

  • Dr.Agarwals Eye Hospital Limited

  • PB Fintech Limited

  • Jubilant Ingrevia Limited

  • Onesource Specialty Pharma Limited

  • 182 Days Tbill (MD 04/09/2025)

  • 364 Days Tbill (MD 03/10/2025)

  • Laxmi Dental Limited

  • Zota Health Care Limited

  • Aster DM Healthcare Limited

  • Mankind Pharma Limited

  • Poly Medicure Limited

  • 364 Days Tbill (MD 28/08/2025)

  • 91 Days Tbill (MD 25/09/2025)

  • 91 Days Tbill (MD 16/10/2025)

  • 182 Days Tbill (MD 23/10/2025)

  • 182 Days Tbill (MD 07/08/2025)

  • 91 Days Tbill (MD 23/10/2025)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Medical Equipment/Supplies/Accessories

  • Plastic Products

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹409.43 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.1(-0.76%)yesterday to ₹13.603.

Among its top 3 holdings the fund has exposure to Max Healthcare Institute Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643